China SXT Pharmaceuticals (SXTC) Debt Ratio (2018 - 2025)

Historic Debt Ratio for China SXT Pharmaceuticals (SXTC) over the last 8 years, with Q3 2025 value amounting to 0.0.

  • China SXT Pharmaceuticals' Debt Ratio fell 9879.34% to 0.0 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.0, marking a year-over-year decrease of 9879.34%. This contributed to the annual value of 0.0 for FY2025, which is 8162.16% down from last year.
  • As of Q3 2025, China SXT Pharmaceuticals' Debt Ratio stood at 0.0, which was down 9879.34% from 0.0 recorded in Q1 2025.
  • China SXT Pharmaceuticals' Debt Ratio's 5-year high stood at 0.35 during Q1 2021, with a 5-year trough of 0.0 in Q1 2022.
  • Over the past 5 years, China SXT Pharmaceuticals' median Debt Ratio value was 0.04 (recorded in 2022), while the average stood at 0.1.
  • As far as peak fluctuations go, China SXT Pharmaceuticals' Debt Ratio skyrocketed by 358335.06% in 2021, and later crashed by 9990.34% in 2022.
  • Over the past 5 years, China SXT Pharmaceuticals' Debt Ratio (Quarter) stood at 0.09 in 2021, then tumbled by 41.79% to 0.05 in 2022, then soared by 228.13% to 0.18 in 2023, then surged by 36.74% to 0.24 in 2024, then crashed by 98.79% to 0.0 in 2025.
  • Its Debt Ratio was 0.0 in Q3 2025, compared to 0.0 in Q1 2025 and 0.24 in Q3 2024.